Literature DB >> 31894095

A new kid on the block for acute myeloid leukemia treatment? Homoharringtonine interferes with key pathways in acute myeloid leukemia cells.

Stefan K Bohlander1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31894095      PMCID： PMC6939538          DOI： 10.3324/haematol.2019.234880

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

Review 1.  MYC as a regulator of ribosome biogenesis and protein synthesis.

Authors:  Jan van Riggelen; Alper Yetil; Dean W Felsher
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

2.  Homoharringtonine in combination with cytarabine and aclarubicin resulted in high complete remission rate after the first induction therapy in patients with de novo acute myeloid leukemia.

Authors:  J Jin; D-Z Jiang; W-Y Mai; H-T Meng; W-B Qian; H-Y Tong; J Huang; L-P Mao; Y Tong; L Wang; Z-M Chen; W-L Xu
Journal:  Leukemia       Date:  2006-06-22       Impact factor: 11.528

3.  Genomic Classification and Prognosis in Acute Myeloid Leukemia.

Authors:  Elli Papaemmanuil; Moritz Gerstung; Hartmut Döhner; Peter J Campbell; Lars Bullinger; Verena I Gaidzik; Peter Paschka; Nicola D Roberts; Nicola E Potter; Michael Heuser; Felicitas Thol; Niccolo Bolli; Gunes Gundem; Peter Van Loo; Inigo Martincorena; Peter Ganly; Laura Mudie; Stuart McLaren; Sarah O'Meara; Keiran Raine; David R Jones; Jon W Teague; Adam P Butler; Mel F Greaves; Arnold Ganser; Konstanze Döhner; Richard F Schlenk
Journal:  N Engl J Med       Date:  2016-06-09       Impact factor: 91.245

4.  Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population.

Authors:  Hannah Bower; Magnus Björkholm; Paul W Dickman; Martin Höglund; Paul C Lambert; Therese M-L Andersson
Journal:  J Clin Oncol       Date:  2016-06-20       Impact factor: 44.544

5.  Antitumor alkaloids for Cephalataxus harringtonia: structure and activity.

Authors:  R G Powell; D Weisleder; C R Smith
Journal:  J Pharm Sci       Date:  1972-08       Impact factor: 3.534

Review 6.  Therapeutic advances in acute myeloid leukemia.

Authors:  Alan Burnett; Meir Wetzler; Bob Löwenberg
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

Review 7.  TET-mediated active DNA demethylation: mechanism, function and beyond.

Authors:  Xiaoji Wu; Yi Zhang
Journal:  Nat Rev Genet       Date:  2017-05-30       Impact factor: 53.242

Review 8.  New drugs creating new challenges in acute myeloid leukemia.

Authors:  Ing S Tiong; Andrew H Wei
Journal:  Genes Chromosomes Cancer       Date:  2019-04-11       Impact factor: 5.006

9.  U2504 determines the species specificity of the A-site cleft antibiotics: the structures of tiamulin, homoharringtonine, and bruceantin bound to the ribosome.

Authors:  Güliz Gürel; Gregor Blaha; Peter B Moore; Thomas A Steitz
Journal:  J Mol Biol       Date:  2009-04-09       Impact factor: 5.469

10.  Homoharringtonine exhibits potent anti-tumor effect and modulates DNA epigenome in acute myeloid leukemia by targeting SP1/TET1/5hmC.

Authors:  Chenying Li; Lei Dong; Rui Su; Ying Bi; Ying Qing; Xiaolan Deng; Yile Zhou; Chao Hu; Mengxia Yu; Hao Huang; Xi Jiang; Xia Li; Xiao He; Dongling Zou; Chao Shen; Li Han; Miao Sun; Jennifer Skibbe; Kyle Ferchen; Xi Qin; Hengyou Weng; Huilin Huang; Chunxiao Song; Jianjun Chen; Jie Jin
Journal:  Haematologica       Date:  2019-04-11       Impact factor: 9.941
View more
  1 in total

1.  Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2.

Authors:  Christopher P Mill; Warren Fiskus; Courtney D DiNardo; Christine Birdwell; John A Davis; Tapan M Kadia; Koichi Takahashi; Nicholas Short; Naval Daver; Maro Ohanian; Gautam Borthakur; Steven M Kornblau; Michael R Green; Yuan Qi; Xiaoping Su; Joseph D Khoury; Kapil N Bhalla
Journal:  Blood       Date:  2022-02-10       Impact factor: 25.476
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.